CINECA IRIS Institutional Research Information System

VOLANTE, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.138
EU - Europa 9.745
AS - Asia 5.158
SA - Sud America 499
OC - Oceania 207
AF - Africa 169
Continente sconosciuto - Info sul continente non disponibili 22
Totale 30.938
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.731
CN - Cina 2.698
IT - Italia 2.306
IE - Irlanda 1.015
DE - Germania 966
FR - Francia 889
SE - Svezia 809
UA - Ucraina 599
JP - Giappone 549
FI - Finlandia 490
KR - Corea 474
GB - Regno Unito 457
IN - India 377
PL - Polonia 370
AT - Austria 326
VN - Vietnam 308
CA - Canada 304
BR - Brasile 286
ES - Italia 277
TR - Turchia 235
NL - Olanda 197
AU - Australia 184
BE - Belgio 175
DK - Danimarca 128
GR - Grecia 124
RU - Federazione Russa 113
AR - Argentina 95
CH - Svizzera 92
MX - Messico 87
SN - Senegal 86
TW - Taiwan 82
PT - Portogallo 76
RO - Romania 74
HK - Hong Kong 65
HU - Ungheria 64
IL - Israele 51
CL - Cile 49
CZ - Repubblica Ceca 42
SG - Singapore 42
CO - Colombia 37
TH - Thailandia 36
NO - Norvegia 35
ID - Indonesia 34
PH - Filippine 34
SA - Arabia Saudita 34
DZ - Algeria 30
MY - Malesia 30
HR - Croazia 26
RS - Serbia 26
UZ - Uzbekistan 25
EU - Europa 21
NZ - Nuova Zelanda 21
SI - Slovenia 20
PK - Pakistan 19
EC - Ecuador 15
PE - Perù 12
EG - Egitto 11
SK - Slovacchia (Repubblica Slovacca) 11
ZA - Sudafrica 11
IR - Iran 9
BY - Bielorussia 8
JO - Giordania 8
AM - Armenia 7
BG - Bulgaria 7
QA - Qatar 7
AE - Emirati Arabi Uniti 6
IQ - Iraq 6
MA - Marocco 6
NG - Nigeria 6
SD - Sudan 6
MK - Macedonia 5
PR - Porto Rico 5
BA - Bosnia-Erzegovina 4
LT - Lituania 4
VE - Venezuela 4
BD - Bangladesh 3
MO - Macao, regione amministrativa speciale della Cina 3
MT - Malta 3
MU - Mauritius 3
OM - Oman 3
PA - Panama 3
SC - Seychelles 3
SY - Repubblica araba siriana 3
CU - Cuba 2
CY - Cipro 2
EE - Estonia 2
FJ - Figi 2
GT - Guatemala 2
LB - Libano 2
RE - Reunion 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AZ - Azerbaigian 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GH - Ghana 1
IM - Isola di Man 1
IS - Islanda 1
JM - Giamaica 1
KG - Kirghizistan 1
Totale 30.926
Salva come PNG Salva come JPEG
Città #
Chandler 1.552
Beijing 1.394
Houston 1.131
Fairfield 1.101
Dublin 1.001
Ann Arbor 704
Redwood City 659
Torino 572
Wilmington 571
Woodbridge 567
Ashburn 506
Seattle 463
Villeurbanne 396
Jacksonville 374
Cambridge 368
Pisa 334
Nyköping 332
Vienna 305
Princeton 298
Medford 297
Dearborn 287
Warsaw 262
Dong Ket 173
Boston 151
Shanghai 150
Tokyo 143
Fremont 135
Milan 134
Guangzhou 112
Nanjing 110
Brussels 109
Boardman 96
Hangzhou 95
Würzburg 91
San Diego 80
Chicago 76
New York 75
Turin 72
Seoul 68
Chengdu 65
Toronto 65
Munich 64
São Paulo 62
Paris 55
Norwalk 53
Taipei 51
Düsseldorf 50
London 50
Verona 50
Phoenix 47
Hefei 46
Falls Church 45
Madrid 45
Rome 45
Bologna 44
Zhengzhou 44
Buenos Aires 43
Shenyang 43
Athens 42
Istanbul 42
Santiago 42
Washington 42
Pittsburgh 40
Silver Spring 39
New Delhi 38
Brescia 37
Bethesda 36
Canberra 36
Ankara 35
Florence 35
Wuhan 35
Mountain View 33
Padova 32
Kunming 31
Rochester 31
Amsterdam 30
Budapest 30
Jinan 30
Central District 29
Birmingham 28
Lexington 28
Los Angeles 28
Philadelphia 28
Barcelona 26
Changsha 26
Dallas 26
Hebei 26
Tappahannock 26
Delhi 25
Moscow 25
Piemonte 25
Gurgaon 24
Montréal 24
Lyon 22
Mexico 22
Napoli 22
Oslo 22
Zurich 22
Berlin 20
Calgary 20
Totale 17.571
Salva come PNG Salva come JPEG
Nome #
The weiss score and beyond--histopathology for adrenocortical carcinoma. 1.356
The Reticulin Algorithm for Adrenocortical Tumor Diagnosis: A Multicentric Validation Study on 245 Unpublished Cases. 910
Cytological features of "noninvasive follicular thyroid neoplasm with papillary-like nuclear features" and their correlation with tumor histology 842
Validation of the prognostic role of the "Helsinki Score" in 225 cases of adrenocortical carcinoma 596
Adrenocortical tumors with myxoid features: a distinct morphologic and phenotypical variant exhibiting malignant behavior. 587
Mixed Adenoneuroendocrine Carcinomas (MANECs) of the Gastrointestinal Tract: Targeted Next Generation Sequencing Suggests a Monoclonal Origin of the Two Components 525
Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study. 488
β1 integrin controls EGFR signaling and tumorigenic properties of lung cancer cells. 458
IMPACT OF PREGNANCY ON PROGNOSIS OF DIFFERENTIATED THYROID CANCER: CLINICAL AND MOLECULAR FEATURES. 406
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane. 399
Oncocytic Adrenocortical Tumors: Diagnostic Algorithm and Mitochondrial DNA Profile in 27 Cases. 394
Tumor staging but not grading is associated with adverse clinical outcome in neuroendocrine tumors of the appendix: a retrospective clinical pathologic analysis of 138 cases. 379
Long-Term Outcomes of Adjuvant Mitotane Therapy in Patients With Radically Resected Adrenocortical Carcinoma. 370
Obestatin regulates adipocyte function and protects against diet-induced insulin resistance and inflammation. 351
Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart 338
Extrapulmonary neuroendocrine small and large cell carcinomas: a review of controversial diagnostic and therapeutic issues. 332
RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact 312
Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones 312
Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigm 294
Functional Role and Prognostic Significance of CD157 in Ovarian Carcinoma 288
Therapeutic Biomarkers in Lung Neuroendocrine Neoplasia 280
Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification. 275
Prognostic Role of Overt Hypercortisolism in Completely Operated Patients with Adrenocortical Cancer 273
microRNA expression patterns in adrenocortical carcinoma variants and clinical pathologic correlations 272
An exploration of pathways involved in lung carcinoid progression using gene expression profiling 271
Thymidylate synthase is functionally associated with ZEB1 and contributes to the epithelial-to-mesenchymal transition of cancer cells 269
MITOTANE LEVELS PREDICT THE OUTCOME OF PATIENTS WITH ADRENOCORTICAL CARCINOMA TREATED ADJUVANTLY FOLLOWING RADICAL RESECTION. 268
An international Ki67 reproducibility study in adrenal cortical Carcinoma 257
Targeted next-generation sequencing of cancer genes in advanced stage malignant pleural mesothelioma: a retrospective study. 250
Poorly differentiated thyroid carcinoma: 5 years after the 2004 WHO classification of endocrine tumours. 248
Pathology of the Adrenal Cortex: a Reappraisal of the Past 25 Years Focusing on Adrenal Cortical Tumors. 247
Somatostatin receptor tissue distribution in lung neuroendocrine tumours: a clinicopathologic and immunohistochemical study of 218 'clinically aggressive' cases. 241
RRM1 modulates mitotane activity in adrenal cancer cells interfering with its metabolization 234
Expression of cortistatin and MrgX2, a specific cortistatin receptor, in human neuroendocrine tissues and related tumours 232
Diagnostic and prognostic role of steroidogenic factor 1 in adrenocortical carcinoma: a validation study focusing on clinical and pathologic correlates 230
Mammalian target of rapamycin pathway activation is associated to RET mutation status in medullary thyroid carcinoma. 227
Comparative diagnostic and prognostic performances of the hematoxylin-eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma 216
MEN1 Gene Mutation and Reduced Expression Are Associated with Poor Prognosis in Pulmonary Carcinoids 215
Sarcomatoid adrenocortical carcinoma: a comprehensive pathological, immunohistochemical, and targeted next-generation sequencing analysis 214
Retrospective multicenter study investigating the role of targeted next-generation sequencing of selected cancer genes in mucinous adenocarcinoma of the lung 212
Cytotoxic activity of gemcitabine, alone or in combination with mitotane, in adrenocortical carcinoma cell lines. 208
Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma 203
YAP-Dependent AXL Overexpression Mediates Resistance to EGFR Inhibitors in NSCLC 194
Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence. 190
Differential expression of HER2, STAT3, SOX2, IFI16 and cell cycle markers during HPV-related head and neck carcinogenesis 186
Unusual paraneoplastic neurological syndrome secondary to a well differentiated pancreatic neuroendocrine tumor: A case report and review of the literature 186
Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer 183
Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma 178
Brca1-Associated Protein 1 (BAP1) Immunohistochemical Expression as a Diagnostic Tool in Malignant Pleural Mesothelioma Classification: a Large Retrospective Study 175
H-RAS mutations are restricted to sporadic pheochromocytomas lacking specific clinical or pathological features data from a multi-institutional series 172
Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors 168
Detection and characterization of classical and "uncommon" exon 19 Epidermal Growth Factor Receptor mutations in lung cancer by pyrosequencing 166
mTORC1 Complex is Significantly Over-Activated in SDHX-Mutated Paragangliomas 165
CD157 enhances malignant pleural mesothelioma aggressiveness and predicts poor clinical outcome. 160
Mammalian target of rapamycin signaling activation patterns in neuroendocrine tumors of the lung. 160
Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted Therapies 160
Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the xelbevoct study. 157
Effects of Src kinase inhibition induced by dasatinib in non-small cell lung cancer cell lines treated with cisplatin 154
Bevacizumab Plus Octreotide and Metronomic Capecitabine in Patients with Metastatic Well-to-Moderately Differentiated Neuroendocrine Tumors. The XELBEVOCT Multicenter Phase II Study 151
Retrospective study testing next generation sequencing of selected cancer-associated genes in resected prostate cancer 150
Increased neuroendocrine cells in resected metastases compared to primary colorectal adenocarcinomas. 149
Expression of SOAT1 in Adrenocortical Carcinoma and Response to Mitotane Monotherapy: An ENSAT Multicenter Study 145
Retrospective evaluation of the outcome of open versus laparoscopic adrenalectomy for stage I and II adrenocortical cancer. 142
Inhibition of human respiratory syncytial virus infectivity by a dendrimeric heparan sulfate-binding peptide. 133
SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: A multicenter interobserver variation analysis using virtual microscopy: A Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T) 127
Tissue arrays as fiducial markers for section alignment in 3-D reconstruction technology 122
CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer 121
Thymidylate synthase expression in large cell carcinoma ofthe lung 118
Highly Sulfated K5 Escherichia coli Polysaccharide Derivatives Inhibit Respiratory Syncytial Virus Infectivity in Cell Lines and Human Tracheal-Bronchial Histocultures 118
PAX8–GLIS3 gene fusion is a pathognomonic genetic alteration of hyalinizing trabecular tumors of the thyroid 117
CYP2W1 Is Highly Expressed in Adrenal Glands and Is Positively Associated with the Response to Mitotane in Adrenocortical Carcinoma 115
Biological role, clinical significance and potential therapeutic applications of CD157 in ovarian cancer 114
RFamide peptides 43RFa and 26RFa both promote survival of pancreatic β-cells and human pancreatic islets but exert opposite effects on insulin secretion. 111
Ribonucleotide Reductase Large Subunit (RRM1) Gene Expression May Predict Efficacy of Adjuvant Mitotane in Adrenocortical Cancer. 111
Biological role and clinical significance of CD157 in epithelial ovarian cancer 109
INHIBITION OF USP7 INDUCES SELECTIVE CANCER CELL DEATH IN CHRONIC LYMPHOCYTIC LEUKEMIA THROUGH PTEN AND INDEPENDENTLY FROM P53 STATUS 109
Mechanical phenotyping of cells and extracellular matrix as grade and stage markers of lung tumor tissues 109
Extensive DNA fragmentation in oxyphilic cell lesions of the thyroid. 107
CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cells 107
Epidermal Growth Factor Receptor Gene in Primary Tumor and Metastatic Sites from Non-small Cell Lung Cancer. J Thorac Oncol. 2009 Apr 29 106
Differential Thymidylate Synthase Expression in Different Variants of Large-Cell Carcinoma of the Lung 103
Integrative analysis of SF-1 transcription factor dosage impact on genome-wide binding and gene expression regulation 101
ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine 101
Caveolin-1 expression in lung carcinoma varies according to tumour histotype and is acquired de novo in brain metastases 100
Anti-CD38 autoantibodies: characterisation in new-onset type I diabetes and latent autoimmune diabetes of the adult (LADA) and comparison with other islet autoantibodies. 99
Desmocollin-3: a new marker of squamous differentiation in undifferentiated large-cell carcinoma of the lung 99
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 99
Absence of gene mutations in a case of concomitant presence of carcinoid of the ampulla of vater pheochromocytoma and Von Recklinghausen disease 97
Valutazione prospettica di pazienti operati radicalmente per carcinoma corticosurrenalico in trattamento con mitotane adiuvante: correlazioni tra indici di massa corporea, livelli di mitotanemia ed efficacia. 97
Adjuvant mitotane treatment: a prospective experience at the San luigi Hospital, University of Turin, Italy, USA, 2008 97
CD157: A New Prognostic and/or Predictive Marker in Ovarian Cancer? A Retrospective Study 97
Clinical and biological significance of CD157 in malignant pleural mesothelioma 96
Soluble CD157 in pleural effusions: a complementary tool for the diagnosis of malignant mesothelioma 96
CD157 is a novel prognostic marker of malignant pleural mesothelioma involved in the control of tumor aggressiveness 93
Cytology of Primary Salivary Gland-Type Tumors of the Lower Respiratory Tract: Report of 15 Cases and Review of the Literature 92
99mTc-MIBI Imaging in the presurgical characterization of thyroid follicular neoplasms: relationship to multidrug resistance protein expression 92
A prospective study on adjuvant mitotane 91
Inhibition OF USP7 Induces Selective Cancer Cell Death in Chronic Lymphocytic Leukemia 90
Bone sialoprotein is predictive of bone metastases in resectable non-small-cell lung cancer: a retrospective case-control study 90
Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte oncology network 89
Totale 22.643
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.695
article - articoli 0
book - libri 0
conference - conferenze 5.003
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.698
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193.338 0 0 0 237 239 232 237 444 243 394 875 437
2019/20205.927 352 348 380 670 490 921 659 487 550 468 328 274
2020/20214.475 365 266 392 259 376 395 444 256 397 404 377 544
2021/20224.312 262 297 252 373 266 237 300 297 189 300 797 742
2022/20235.563 547 449 176 509 473 1.225 458 381 589 190 294 272
2023/20241.082 379 462 235 6 0 0 0 0 0 0 0 0
Totale 32.013